| Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study VL Villemagne, S Burnham, P Bourgeat, B Brown, KA Ellis, O Salvado, ... The Lancet Neurology 12 (4), 357-367, 2013 | 2444* | 2013 |
| Blood-Based Protein Biomarkers for Diagnosis of Alzheimer Disease JD Doecke, SM Laws, NG Faux, W Wilson, SC Burnham, CP Lam, ... Archives of Neurology 69 (10), 1318-1325, 2012 | 474 | 2012 |
| Imaging tau and amyloid-β proteinopathies in Alzheimer disease and other conditions VL Villemagne, V Doré, SC Burnham, CL Masters, CC Rowe Nature Reviews Neurology 14 (4), 225-236, 2018 | 441 | 2018 |
| Physical activity and amyloid-β plasma and brain levels: results from the Australian Imaging, Biomarkers and Lifestyle Study of Ageing BM Brown, JJ Peiffer, K Taddei, JK Lui, SM Laws, VB Gupta, T Taddei, ... Molecular psychiatry 18 (8), 875-881, 2013 | 270 | 2013 |
| Blood-based molecular biomarkers for Alzheimer’s disease H Zetterberg, SC Burnham Molecular brain 12 (1), 26, 2019 | 262 | 2019 |
| Clinical and cognitive trajectories in cognitively healthy elderly individuals with suspected non-Alzheimer's disease pathophysiology (SNAP) or Alzheimer's disease pathology: a … SC Burnham, P Bourgeat, V Doré, G Savage, B Brown, S Laws, P Maruff, ... The Lancet Neurology 15 (10), 1044-1053, 2016 | 228 | 2016 |
| Sex, amyloid, and APOE ε4 and risk of cognitive decline in preclinical Alzheimer's disease: Findings from three well-characterized cohorts RF Buckley, EC Mormino, RE Amariglio, MJ Properzi, JS Rabin, YY Lim, ... Alzheimer's & Dementia 14 (9), 1193-1203, 2018 | 209 | 2018 |
| Intense physical activity is associated with cognitive performance in the elderly BM Brown, JJ Peiffer, HR Sohrabi, A Mondal, VB Gupta, SR Rainey-Smith, ... Translational psychiatry 2 (11), e191-e191, 2012 | 180 | 2012 |
| Aβ-amyloid and tau imaging in dementia VL Villemagne, V Dore, P Bourgeat, SC Burnham, S Laws, O Salvado, ... Seminars in nuclear medicine 47 (1), 75-88, 2017 | 156 | 2017 |
| Alzheimer’s disease: a journey from amyloid peptides and oxidative stress, to biomarker technologies and disease prevention strategies—gains from AIBL and DIAN cohort studies RN Martins, V Villemagne, HR Sohrabi, P Chatterjee, TM Shah, G Verdile, ... Journal of Alzheimer's Disease 62 (3), 965-992, 2018 | 131 | 2018 |
| A blood-based predictor for neocortical Aβ burden in Alzheimer’s disease: results from the AIBL study SC Burnham, NG Faux, W Wilson, SM Laws, D Ames, J Bedo, AI Bush, ... Molecular psychiatry 19 (4), 519-526, 2014 | 129 | 2014 |
| Association of donanemab treatment with exploratory plasma biomarkers in early symptomatic Alzheimer disease: a secondary analysis of the TRAILBLAZER-ALZ randomized clinical trial MJ Pontecorvo, M Lu, SC Burnham, AE Schade, JL Dage, S Shcherbinin, ... JAMA neurology 79 (12), 1250-1259, 2022 | 106 | 2022 |
| Association of β-amyloid and apolipoprotein E ε4 with memory decline in preclinical Alzheimer disease YY Lim, P Kalinowski, RH Pietrzak, SM Laws, SC Burnham, D Ames, ... JAMA neurology 75 (4), 488-494, 2018 | 95 | 2018 |
| Fifteen years of the Australian Imaging, Biomarkers and Lifestyle (AIBL) study: progress and observations from 2,359 older adults spanning the spectrum from cognitive normality … C Fowler, SR Rainey-Smith, S Bird, J Bomke, P Bourgeat, BM Brown, ... Journal of Alzheimer's disease reports 5 (1), 443-468, 2021 | 94 | 2021 |
| Influence of BDNF Val66Met on the relationship between physical activity and brain volume BM Brown, P Bourgeat, JJ Peiffer, S Burnham, SM Laws, ... Neurology 83 (15), 1345-1352, 2014 | 82 | 2014 |
| Insulin resistance is associated with reductions in specific cognitive domains and increases in CSF tau in cognitively normal adults SM Laws, S Gaskin, A Woodfield, V Srikanth, D Bruce, PE Fraser, T Porter, ... Scientific reports 7 (1), 9766, 2017 | 81 | 2017 |
| The feasibility of at-home iPad cognitive testing for use in clinical trials DM Rentz, M Dekhtyar, J Sherman, S Burnham, D Blacker, SL Aghjayan, ... The journal of prevention of Alzheimer's disease 3 (1), 8, 2016 | 73 | 2016 |
| Structural core of the executive control network: A high angular resolution diffusion MRI study K Shen, T Welton, M Lyon, AN McCorkindale, GT Sutherland, S Burnham, ... Human brain mapping 41 (5), 1226-1236, 2020 | 64 | 2020 |
| Computerized cognitive testing for use in clinical trials: a comparison of the NIH Toolbox and Cogstate C3 batteries RF Buckley, KP Sparks, KV Papp, M Dekhtyar, C Martin, S Burnham, ... The journal of prevention of Alzheimer's disease 4 (1), 3, 2017 | 64 | 2017 |
| Australian Imaging B, Lifestyle Research G (2013) Amyloid beta deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer’s disease: A prospective cohort study VL Villemagne, S Burnham, P Bourgeat, B Brown, KA Ellis, O Salvado, ... Lancet Neurol 12 (4), 357-367, 0 | 61 | |
